Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Accounting Policies [Abstract] |
|
| Schedule of Marketable Securities |
The
following is a description of the valuation methodologies used for assets measured at fair value as of September 30, 2026 and December
31, 2025.
Schedule
of Marketable Securities
Marketable
Securities: Valued using quoted prices in active markets for identical assets.
| Description |
|
Level |
|
|
September 30, 2026 |
|
|
December 31, 2025 |
|
| |
|
|
|
|
As of |
|
| Description |
|
Level |
|
|
September 30, 2026 |
|
|
December 31, 2025 |
|
| Marketable securities |
|
|
1 |
|
|
$ |
6,805,270 |
|
|
$ |
14,801,267 |
|
|
| Schedule of Fair Value Hierarchy of the Valuation Inputs |
Schedule
of Fair Value Hierarchy of the Valuation Inputs
| |
|
|
|
|
As of |
|
| Description |
|
Level |
|
|
September 30, 2026 |
|
|
December 31, 2025 |
|
| Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative Liabilities |
|
|
3 |
|
|
$ |
25,000 |
|
|
$ |
2,157,000 |
|
| Contingent Consideration Payable |
|
|
3 |
|
|
$ |
- |
|
|
$ |
10,909,000 |
|
|
| Summary of Change in Fair Value of Derivative Liabilities |
The
following table sets forth a summary of the change in the fair value of the derivative liabilities that is measured at fair value on
a recurring basis for the nine months ended September 30, 2026 and 2025, respectively:
Summary
of Change in Fair Value of Derivative Liabilities
| Description |
|
2026 |
|
|
2025 |
|
| Balance on December 31, 2025 and 2024 |
|
$ |
2,157,000 |
|
|
$ |
1,303,000 |
|
| Changes in fair value of derivative liabilities |
|
|
(510,000 |
) |
|
|
(1,284,000 |
) |
| Balance on March 31, |
|
$ |
1,647,000 |
|
|
|
19,000 |
|
| Changes in fair value of derivative liabilities |
|
|
(81,000 |
) |
|
|
(19,000 |
) |
| Balance on June 30, |
|
$ |
1,566,000 |
|
|
$ |
- |
|
| Issuance of derivatives reported at fair value |
|
|
- |
|
|
|
1,837,000 |
|
| Changes in fair value of derivative liabilities |
|
|
(1,541,000 |
)- |
|
|
1,059,000 |
|
| Balance on September 30, |
|
$ |
25,000 |
|
|
$ |
2,896,000 |
|
|
| Schedule of Estimated Useful Lives of Property Plant and Equipment |
The
estimated useful lives for the current and comparative periods are as follows:
Schedule
of Estimated Useful Lives of Property Plant and Equipment
| |
|
Useful Life |
| |
|
(in
years) |
| Plant and equipment |
|
5-12 |
| Furniture and fixtures |
|
5-10 |
| Computer equipment & software |
|
3-5 |
| Leasehold Improvements |
|
Shorter of the remaining
lease or estimated useful life |
|
| Schedule of Estimated Useful lives of Intangible Assets |
Amortization
is recognized on a straight-line basis over the estimated useful lives of intangible assets, other than goodwill, from the date that
they are available for use. The estimated useful lives for the current and comparative periods are as follows:
Schedule
of Estimated Useful lives of Intangible Assets
| |
|
Useful Life |
| |
|
(in
years) |
| Patents and trademarks |
|
12-17 |
|
| Schedule of Condensed Consolidated Balance Sheet Information Related to Operating Lease |
The
Company’s operating leases are comprised of the 333 Bush Street Lease on the Condensed Consolidated Balance Sheets. The information
related to these leases is presented below.
Schedule of Condensed Consolidated Balance Sheet Information Related to Operating Lease
| Balance Sheet Location |
|
Lease |
|
|
Lease |
|
|
Total |
|
|
Lease |
|
|
Lease |
|
|
Total |
|
| |
|
As of September 30, 2026 |
|
|
As of December 31, 2025 |
|
| |
|
2024 Baltimore |
|
|
333 Bush Street |
|
|
|
|
|
2024 Baltimore |
|
|
333 Bush Street |
|
|
|
|
| Balance Sheet Location |
|
Lease |
|
|
Lease |
|
|
Total |
|
|
Lease |
|
|
Lease |
|
|
Total |
|
| Operating Lease |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lease Right of Use |
|
$ |
- |
|
|
$ |
326,315 |
|
|
$ |
326,315 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
| Lease Payable, current |
|
|
- |
|
|
|
189,112 |
|
|
|
189,112 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Lease Payable - net of current |
|
|
- |
|
|
|
158,482 |
|
|
|
158,482 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
| Schedule of Lease Expense |
The
following provides details of the Company’s lease expense:
Schedule of Lease Expense
| Lease Expenses |
|
Lease |
|
|
Lease |
|
|
Total |
|
|
Lease |
|
|
Lease |
|
|
Total |
|
| |
|
For the Three Months Ended September 30, 2026
|
|
|
For the Three Months Ended September 30, 2025
|
|
| |
|
2024 Baltimore |
|
|
333 Bush Street |
|
|
|
|
|
2024 Baltimore |
|
|
333 Bush Street |
|
|
|
|
| Lease Expenses |
|
Lease |
|
|
Lease |
|
|
Total |
|
|
Lease |
|
|
Lease |
|
|
Total |
|
| Operating Leases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lease Costs |
|
$ |
- |
|
|
$ |
51,609 |
|
|
$ |
51,609 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
| Lease Expenses |
|
Lease |
|
|
Lease |
|
|
Total |
|
|
Lease |
|
|
Lease |
|
|
Total |
|
| |
|
For the Nine Months Ended September 30, 2026
|
|
|
For the Nine Months Ended September 30, 2025
|
|
| |
|
2024 Baltimore |
|
|
333 Bush Street |
|
|
|
|
|
2024 Baltimore |
|
|
333 Bush Street |
|
|
|
|
| Lease Expenses |
|
Lease |
|
|
Lease |
|
|
Total |
|
|
Lease |
|
|
Lease |
|
|
Total |
|
| Operating Leases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lease Costs |
|
$ |
- |
|
|
$ |
69,099 |
|
|
$ |
69,099 |
|
|
$ |
10,800 |
|
|
$ |
- |
|
|
$ |
10,800 |
|
|
| Schedule of Other Lease Information |
Other
information as of September 30, 2026, related to leases is presented below:
Schedule of Other Lease Information
| |
|
2024 Baltimore |
|
|
333 Bush Street |
|
|
|
|
| Balance Sheet Location |
|
Lease |
|
|
Lease |
|
|
Total |
|
| Operating Leases |
|
|
|
|
|
|
|
|
|
|
|
|
| Operating cash used |
|
$ |
- |
|
|
$ |
29,959 |
|
|
$ |
29,959 |
|
| Weighted average remaining lease term (in years) |
|
|
- |
|
|
|
1.75 |
|
|
|
1.75 |
|
| Discount rate |
|
|
0.0 |
% |
|
|
10.58 |
% |
|
|
10.58 |
% |
|
| Schedule of Weighted Average Number of Shares Outstanding Earnings Per Share |
For
the three and nine months ended September 30, 2026 and 2025, the following securities are excluded from the calculation of weighted average
dilutive Common Stock because their inclusion would have been anti-dilutive.
Schedule of Weighted Average Number of Shares Outstanding Earnings Per Share
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| |
|
For the Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| Stock Options |
|
|
763,084 |
|
|
|
2,819 |
|
|
|
584,230 |
|
|
|
1,943 |
|
| Unvested Restricted Stock Units |
|
|
182,168 |
|
|
|
484 |
|
|
|
305,568 |
|
|
|
484 |
|
| Warrants to purchase Common Stock |
|
|
10,467,804 |
|
|
|
4,823,701 |
|
|
|
10,400,106 |
|
|
|
2,539,277 |
|
| Series D Convertible Preferred Stock |
|
|
13 |
|
|
|
13 |
|
|
|
13 |
|
|
|
13 |
|
| Series G Convertible Preferred Stock |
|
|
2,613,828 |
|
|
|
2,657,135 |
|
|
|
2,612,049 |
|
|
|
2,598,701 |
|
| Series H Convertible Preferred Stock |
|
|
923,976 |
|
|
|
1,799,603 |
|
|
|
923,976 |
|
|
|
1,799,603 |
|
| Series I Convertible Preferred Stock |
|
|
- |
|
|
|
665,030 |
|
|
|
- |
|
|
|
665,030 |
|
| Total potentially dilutive shares |
|
|
14,950,873 |
|
|
|
9,948,785 |
|
|
|
14,825,942 |
|
|
|
7,605,051 |
|
|